ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities – Role of gut microbiota dysbiosis
Open accessThe DOI matches its Crossref record; 172 of the 172 references it cites were found in a registry or an index.
Abstract
Coronavirus disease 19 (COVID-19) is a pandemic condition caused by the new coronavirus SARS-CoV-2. The typical symptoms are fever, cough, shortness of breath, evolving to a clinical picture of pneumonia and, ultimately, death. Nausea and diarrhea are equally frequent, suggesting viral infection or transmission via the gastrointestinal-enteric system. SARS-CoV-2 infects human cells by using angiotensin converting enzyme 2 (ACE2) as a receptor, which is cleaved by transmembrane proteases during host cells infection, thus reducing its activities. ACE2 is a relevant player in the renin-angiotensin system (RAS), counterbalancing the deleterious effects of angiotensin II. Furthermore, intestinal ACE2 functions as a chaperone for the aminoacid transporter B0AT1. It has been suggested that B0AT1/ACE2 complex in the intestinal epithelium regulates gut microbiota (GM) composition and function, with important repercussions on local and systemic immune responses against pathogenic agents, namely virus. Notably, productive infection of SARS-CoV-2 in ACE2+ mature human enterocytes and patients’ GM dysbiosis was recently demonstrated. This review outlines the evidence linking abnormal ACE2 functions with the poor outcomes (higher disease severity and mortality rate) in COVID-19 patients with pre-existing age-related comorbidities and addresses a possible role for GM dysbiosis. The article culminates with the therapeutics opportunities based on these pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19
Mehra, M. R., Desai, S. S., Kuy, S., Henry, T. D., & Patel, A. N. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007621 · Cited by 1,428 · cited 2×
“In fact, strong epidemiological and biochemical data coming from the COVID19 pandemics shows that elderly people with pre-existing cardiovascular, metabolic, renal, and lung diseases (including hypertension, coronary disease, diabetes, CKD and respiratory syndromes) are at higher risk of severe disease and mortality w…”
RetractedAngelakis, E., Million, M., Kankoe, S., Lagier, J.-C., Armougom, F., Giorgi, R., & Raoult, D. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02437-14 · Cited by 99
RetractedClinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884 · cited 1×
“IL-1, IL-2, IL-7, G-CSF, IP-10, MCP-1, MIP-1A and TNFα) observed in COVID19 severe cases (Huang et al., 2020).”
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286 · cited 3×
“The discover that ACE2 is the receptor for SARS-CoV-2 entry in human cells (Hoffmann et al., 2020b) has raised the possibility of ACE2 and/or other RAS modulators to potentially treat COVID-19 (Zhang et al., 2020a).”
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148 · cited 4×
“Notably, abdominal pain was more frequent in ICU admitted patients than in individuals who did not required ICU assistance (Wang et al., 2020a).”
InfluentialLa certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
Pattern Recognition Receptors and Inflammation
Takeuchi, O., & Akira, S. (2010) · Cell · doi:10.1016/j.cell.2010.01.022 · Cited by 8,895 · cited 1×
“While viral antigens are recognized by endosomal and cytoplasmic PRRs, commensal gut microbiota helps to set a homeostatic type I IFN-dependent immune response at distal non-GI tract sites, a central component for virus control (Ma et al., 2018; Takeuchi and Akira, 2010).”
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein
Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020) · doi:10.1101/2020.02.19.956581 · Cited by 8,586
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Lai, C.-C., Shih, T.-P., Ko, W.-C., Tang, H.-J., & Hsueh, P.-R. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105924 · Cited by 6,068 · cited 2×
“Evidence of human‐to‐human transmission was confirmed via respiratory droplets or direct contact with the infected patients, and this new coronavirus infection was further named COVID-19 (Lai et al., 2020; Li et al., 2020c) and recognized by World Health Organization as an ongoing coronavirus pandemic in march 11, 202…”
Role of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385 · cited 1×
“Major advances in our understanding of the mutual interplay between host immune system and gut microbiota have been achieved in the last decade (Belkaid and Hand, 2014).”
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
Yan, R., Zhang, Y., Li, Y., Xia, L., Guo, Y., & Zhou, Q. (2020) · Science · doi:10.1126/science.abb2762 · Cited by 5,040 · cited 1×
“Full-length ACE2 consists of an N- terminal peptidase domain (PD) and a C-terminal collectrin-like domain (CLD) that ends with a single transmembrane helix and an intracellular tail (Guang et al., 2012; Yan et al., 2020).”
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
Koeth, R. A., Wang, Z., Levison, B. S., Buffa, J. A., Org, E., Sheehy, B. T., Britt, E. B., Fu, X., Wu, Y., Li, L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3145 · Cited by 4,386
Wan, Y., Shang, J., Graham, R., Baric, R. S., & Li, F. (2020) · Journal of Virology · doi:10.1128/jvi.00127-20 · Cited by 4,341
Gut microbiota in health and disease
Sekirov, I., Russell, S. L., Antunes, L. C. M., & Finlay, B. B. (2010) · Physiological Reviews · doi:10.1152/physrev.00045.2009 · Cited by 4,182 · cited 1×
“Gut microflora plays major functions for the host homeostasis, including metabolic effects, structural protection against pathobionts (namely preserving the intestinal barrier composition and permeability), as well as “education” of host immunity (Kumar Singh et al., 2019; Sekirov et al., 2010).”
Structural basis of receptor recognition by SARS-CoV-2
Shang, J., Ye, G., Shi, K., Wan, Y., Luo, C., Aihara, H., Geng, Q., Auerbach, A., & Li, F. (2020) · Nature · doi:10.1038/s41586-020-2179-y · Cited by 3,661 · cited 2×
“Host proteases for Sprotein priming, receptor binding and cell entry include type 2 transmembrane protease serine 2 (TMPRSS2) as well as cathepsin L, cathepsin B, trypsin, factor X, furin, and elastase (Hoffmann et al., 2020a; Shang et al., 2020; Wu et al., 2020a).”
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., Zhang, Y., Deng, W., et al. (2005) · Nature Medicine · doi:10.1038/nm1267 · Cited by 3,445 · cited 1×
“Regarding acute lung injury of distinct etiologies, including the one induced by SARS-CoV, rhACE2 also promoted beneficial effects (Imai et al., 2005; Jia, 2016; Kuba et al., 2005).”
Emerging coronaviruses: Genome structure, replication, and pathogenesis
Chen, Y., Liu, Q., & Guo, D. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25681 · Cited by 3,062
Evidence for gastrointestinal infection of SARS-CoV-2
Xiao, F., Tang, M., Zheng, X., Liu, Y., Li, X., & Shan, H. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.02.055 · Cited by 2,836
Zhang, H., Penninger, J. M., Li, Y., Zhong, N., & Slutsky, A. S. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05985-9 · Cited by 2,684
Channappanavar, R., & Perlman, S. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0629-x · Cited by 2,524 · cited 2×
“These findings are in line with the high-levels of pro-inflammatory cytokines (e.g. IL-1, IL-2, IL-7, G-CSF, IP-10, MCP-1, MIP-1A and TNFα) observed in COVID19 severe cases (Huang et al., 2020).”
Angiotensin-converting enzyme 2 protects from severe acute lung failure
Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B., Yang, P., Sarao, R., Wada, T., Leong-Poi, H., et al. (2005) · Nature · doi:10.1038/nature03712 · Cited by 2,453 · cited 3×
“Regarding acute lung injury of distinct etiologies, including the one induced by SARS-CoV, rhACE2 also promoted beneficial effects (Imai et al., 2005; Jia, 2016; Kuba et al., 2005).”
Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China
Wu, A., Peng, Y., Huang, B., Ding, X., Wang, X., Niu, P., Meng, J., Zhu, Z., Zhang, Z., Wang, J., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.02.001 · Cited by 2,361
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review
Sanders, J. M., Monogue, M. L., Jodlowski, T. Z., & Cutrell, J. B. (2020) · JAMA · doi:10.1001/jama.2020.6019 · Cited by 2,347 · cited 2×
“inflammatory agents, as well as drugs targeting a functional receptor for SARS-CoV-2 entry into human cells, the angiotensin converting enzyme 2 (ACE2) (Li et al., 2020b; Sanders et al., 2020; Shanmugaraj et al., 2020; Zhang and Liu, 2020).”
CDC COVID-19 Response Team, CDC COVID-19 Response Team, Bialek, S., Boundy, E., Bowen, V., Chow, N., Cohn, A., Dowling, N., Ellington, S., Gierke, R., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6912e2 · Cited by 2,277
Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19
Vaduganathan, M., Vardeny, O., Michel, T., McMurray, J. J. V., Pfeffer, M. A., & Solomon, S. D. (2020) · New England Journal of Medicine · doi:10.1056/nejmsr2005760 · Cited by 2,101
Coronavirus envelope protein: current knowledge
Schoeman, D., & Fielding, B. C. (2019) · Virology Journal · doi:10.1186/s12985-019-1182-0 · Cited by 2,074 · cited 1×
“Although enzootic infections in birds and mammals are more usual, coronaviruses have been infecting humans as well in the last decades (Schoeman and Fielding, 2019).”
Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China
Li, B., Yang, J., Zhao, F., Zhi, L., Wang, X., Liu, L., Bi, Z., & Zhao, Y. (2020) · Clinical Research in Cardiology · doi:10.1007/s00392-020-01626-9 · Cited by 2,057
Prolonged presence of SARS-CoV-2 viral RNA in faecal samples
Wu, Y., Guo, C., Tang, L., Hong, Z., Zhou, J., Dong, X., Yin, H., Xiao, Q., Tang, Y., Qu, X., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30083-2 · Cited by 1,547
Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic
(2020) · Asian Pacific Journal of Allergy and Immunology · doi:10.12932/ap-200220-0772 · Cited by 1,537 · cited 2×
“By looking at the previous outbreak of SARS and MERS, the mechanisms of how SARS-CoV and MERS-CoV evade host immunity greatly depend on the inhibition of the canonical type I IFN antiviral response (Prompetchara et al., 2020).”
Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization
Zuo, T., Zhang, F., Lui, G. C. Y., Yeoh, Y. K., Li, A. Y. L., Zhan, H., Wan, Y., Chung, A. C. K., Cheung, C. P., Chen, N., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.05.048 · Cited by 1,537
Du, R.-H., Liang, L.-R., Yang, C.-Q., Wang, W., Cao, T.-Z., Li, M., Guo, G.-Y., Du, J., Zheng, C.-L., Zhu, Q., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00524-2020 · Cited by 1,452
Impact of the gut microbiota on inflammation, obesity, and metabolic disease
Boulangé, C. L., Neves, A. L., Chilloux, J., Nicholson, J. K., & Dumas, M.-E. (2016) · Genome Medicine · doi:10.1186/s13073-016-0303-2 · Cited by 1,438
Immunosenescence and Inflamm-Aging As Two Sides of the Same Coin: Friends or Foes?
Fulop, T., Larbi, A., Dupuis, G., Le Page, A., Frost, E. H., Cohen, A. A., Witkowski, J. M., & Franceschi, C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01960 · Cited by 1,364 · cited 1×
“Strikingly, these conditions are often caused by multi-organ failure mainly in elderly patients with chronic comorbidities displaying a self-sustaining loop of immunosenescence and inflammaging (Franceschi et al., 2017; Fulop et al., 2017).”
Potential interventions for novel coronavirus in China: A systematic review
Zhang, L., & Liu, Y. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25707 · Cited by 1,348 · cited 1×
“inflammatory agents, as well as drugs targeting a functional receptor for SARS-CoV-2 entry into human cells, the angiotensin converting enzyme 2 (ACE2) (Li et al., 2020b; Sanders et al., 2020; Shanmugaraj et al., 2020; Zhang and Liu, 2020).”
ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation
Hashimoto, T., Perlot, T., Rehman, A., Trichereau, J., Ishiguro, H., Paolino, M., Sigl, V., Hanada, T., Hanada, R., Lipinski, S., et al. (2012) · Nature · doi:10.1038/nature11228 · Cited by 1,271 · cited 4×
“Experimentally, gain or loss of ACE2 function have been associated with amelioration and worsening of leaky gut conditions, respectively (Duan et al., 2019; Hashimoto et al., 2012).”
InfluentialMiddle East respiratory syndrome
Zumla, A., Hui, D. S., & Perlman, S. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60454-8 · Cited by 1,263 · cited 1×
“The lethality of coronaviruses infection after crossing this species barrier is high, as demonstrated by the outbreak of severe acute respiratory syndrome (SARS) in 2002, followed by the Middle East respiratory syndrome (MERS) in 2012, originated by SARS‐CoV and MERS‐CoV, respectively (Coleman and Frieman, 2014; Zumla…”
Tang, W. H. W., Wang, Z., Kennedy, D. J., Wu, Y., Buffa, J. A., Agatisa-Boyle, B., Li, X. S., Levison, B. S., & Hazen, S. L. (2015) · Circulation Research · doi:10.1161/circresaha.116.305360 · Cited by 1,223
O’Toole, P. W., & Jeffery, I. B. (2015) · Science · doi:10.1126/science.aac8469 · Cited by 1,202
Gut Microbiomes of Malawian Twin Pairs Discordant for Kwashiorkor
Smith, M. I., Yatsunenko, T., Manary, M. J., Trehan, I., Mkakosya, R., Cheng, J., Kau, A. L., Rich, S. S., Concannon, P., Mychaleckyj, J. C., et al. (2013) · Science · doi:10.1126/science.1229000 · Cited by 1,173 · cited 1×
“In fact, children from rural regions of Malawi, with a low protein diet, were unable to develop microbiota gene diversity in the adulthood (Smith et al., 2013).”
Coronavirus disease 2019 (COVID-19): current status and future perspectives
Li, H., Liu, S.-M., Yu, X.-H., Tang, S.-L., & Tang, C.-K. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105951 · Cited by 1,156
Astuti, I., & Ysrafil (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.04.020 · Cited by 1,070
Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
Reynolds, H. R., Adhikari, S., Pulgarin, C., Troxel, A. B., Iturrate, E., Johnson, S. B., Hausvater, A., Newman, J. D., Berger, J. S., Bangalore, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2008975 · Cited by 1,063 · cited 1×
“Identical conclusions were obtained in other relevant studies and publications (Fernandez-Ruiz, 2020; Reynolds et al., 2020), including in a multinational open science cohort study involving 1.”
Age-dependent dysregulation of innate immunity
Shaw, A. C., Goldstein, D. R., & Montgomery, R. R. (2013) · Nature Reviews Immunology · doi:10.1038/nri3547 · Cited by 1,061 · cited 2×
“Yet, in a given environment, deregulated immune responses to external factors may become particularly relevant, namely in the case of older individuals coping with infected pathogens (Shaw et al., 2013).”
Franceschi, C., Garagnani, P., Vitale, G., Capri, M., & Salvioli, S. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.09.005 · Cited by 997
TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes
Zang, R., Castro, M. F. G., McCune, B. T., Zeng, Q., Rothlauf, P. W., Sonnek, N. M., Liu, Z., Brulois, K. F., Wang, X., Greenberg, H. B., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abc3582 · Cited by 982 · cited 1×
“Yet, SARS-CoV-2 was rapidly inactivated by simulated human colonic fluid and infectious viruses were not recovered from the stool specimens of COVID-19 patients (Zang et al., 2020).”
Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme
Harmer, D., Gilbert, M., Borman, R., & Clark, K. L. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03640-2 · Cited by 852 · cited 1×
“A non-catalytic, yet functional role for ACE2 was first hypothesized upon the observation of a constitutive ACE2 expression within the luminal surface of differentiated small intestinal epithelial cells and colonic crypt cells (Harmer et al., 2002).”
Role of the ACE2/angiotensin 1-7 axis of the renin-angiotensin system in heart failure
Patel, V. B., Zhong, J.-C., Grant, M. B., & Oudit, G. Y. (2016) · Circulation Research · doi:10.1161/circresaha.116.307708 · Cited by 833 · cited 2×
“Thus, the ACE2/Ang 1–7/MasR axis over time was established as the physiological counter-regulator of Ang II in the RAS (Patel et al., 2016; Zhong et al., 2010).”
COVID-19: what has been learned and to be learned about the novel coronavirus disease
Yi, Y., Lagniton, P. N. P., Ye, S., Li, E., & Xu, R.-H. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.45134 · Cited by 832
Enteric involvement of coronaviruses: is faecal–oral transmission of SARS-CoV-2 possible?
Yeo, C., Kaushal, S., & Yeo, D. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30048-0 · Cited by 817 · cited 1×
“further compromise the host’s immune response to the infection and potentiate adverse outcomes, as detailed in Section 3 (Leung et al., 2003; Yeo et al., 2020).”
Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza
Gu, S., Chen, Y., Wu, Z., Chen, Y., Gao, H., Lv, L., Guo, F., Zhang, X., Luo, R., Huang, C., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa709 · Cited by 788 · cited 1×
“Streptococcus, Rothia, Actinomyces) and a lower relative abundance of beneficial symbionts (Gu et al., 2020; Zuo et al., 2020).”
The Gut Microbiome, Kidney Disease, and Targeted Interventions
Ramezani, A., & Raj, D. S. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013080905 · Cited by 743 · cited 1×
“As a result of gut inflammation and of the leaky gut syndrome, LPS translocation stimulates immune system cells towards a massive production of pro-inflammatory cytokines which causes systemic inflammation (Anders et al., 2013; Ramezani and Raj, 2014).”
Impact of Omega-3 Fatty Acids on the Gut Microbiota
Costantini, L., Molinari, R., Farinon, B., & Merendino, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122645 · Cited by 741 · cited 1×
“, 2020); among them, vitamins, selenium and zinc, flavonoids, omega‐3 polyunsaturated fatty acids and a panoply of herbs/compounds from traditional chinese medicine (Costantini et al., 2017; Feng et al., 2019; Kumar Singh et al., 2019; Steinert et al., 2020; Yang et al., 2020).”
Role of gut microbiota in atherosclerosis
Jonsson, A. L., & Bäckhed, F. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.183 · Cited by 644 · cited 2×
“Globally, patients with cardiovascular disease have been associated with major changes on bacterial populations, including an increased prevalence of Firmicutes and reduced of Bacterioidetes (Jonsson and Backhed, 2017).”
Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection
Leung, W. K., To, K.-F., Chan, P. K. S., Chan, H. L. Y., Wu, A. K. L., Lee, N., Yuen, K. Y., & Sung, J. J. Y. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)01215-0 · Cited by 639 · cited 6×
“g diarrhea and other symptoms of GI discomfort) before the appearance of respiratory conditions (Kotfis and Skonieczna-Zydecka, 2020), similarly to what was reported in previous coronavirus outbreaks (Leung et al., 2003).”
InfluentialInnate immune recognition of the microbiota promotes host-microbial symbiosis
Chu, H., & Mazmanian, S. K. (2013) · Nature Immunology · doi:10.1038/ni.2635 · Cited by 630 · cited 1×
“Increasing evidences highlight that commensal gut microbiota-derived ligands, collectively termed microbe-associated molecular patterns (MAMPs), are able to engage PRRs towards a balanced tunning of proand anti-inflammatory responses arising from innate and adaptive host immunity (Chu and Mazmanian, 2013).”
Iwata-Yoshikawa, N., Okamura, T., Shimizu, Y., Hasegawa, H., Takeda, M., & Nagata, N. (2019) · Journal of Virology · doi:10.1128/jvi.01815-18 · Cited by 618 · cited 1×
“Another possibility to halt SARS-CoV-2 entry into host cells that deserves further attention is the inhibition of TMPRSS2 activity (Hoffmann et al., 2020a; Iwata-Yoshikawa et al., 2019).”
Gut Microbiota and Obesity: A Role for Probiotics
Abenavoli, L., Scarpellini, E., Colica, C., Boccuto, L., Salehi, B., Sharifi-Rad, J., Aiello, V., Romano, B., De Lorenzo, A., Izzo, A. A., et al. (2019) · Nutrients · doi:10.3390/nu11112690 · Cited by 615
Gut microbiota and Covid-19- possible link and implications
Dhar, D., & Mohanty, A. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198018 · Cited by 608 · cited 1×
“Regarding nutraceutical interventions, several options able to modulate GM have been recently suggested as potentially useful in combating COVID-19 or its associated symptoms (Akour, 2020; Dhar and Mohanty, 2020; Zabetakis et al., 2020); among them, vitamins, selenium and zinc, flavonoids, omega‐3 polyunsaturated fatt…”
Khan, A., Benthin, C., Zeno, B., Albertson, T. E., Boyd, J., Christie, J. D., Hall, R., Poirier, G., Ronco, J. J., Tidswell, M., et al. (2017) · Critical Care · doi:10.1186/s13054-017-1823-x · Cited by 602 · cited 1×
“It is worth to mention that previous studies with the rhACE2 APN01 (GSK2586881) have shown a safe profile both in healthy volunteers as well as in a small cohort of patients with acute respiratory distress syndrome (Haschke et al., 2013; Khan et al., 2017; Zhang and Baker, 2017).”
The microbial metabolite desaminotyrosine protects from influenza through type I interferon
Steed, A. L., Christophi, G. P., Kaiko, G. E., Sun, L., Goodwin, V. M., Jain, U., Esaulova, E., Artyomov, M. N., Morales, D. J., Holtzman, M. J., et al. (2017) · Science · doi:10.1126/science.aam5336 · Cited by 569 · cited 1×
“Accordingly, a microbial-derived metabolite produced by the human-associated commensal gut bacteria Clostridium orbiscendens – desaminotyrosine – was able to protect mice from lethal Influenza Virus infection, presumably due to the vigorous priming and amplification of type I IFN-dependent antiviral immune response (S…”
Schiattarella, G. G., Sannino, A., Toscano, E., Giugliano, G., Gargiulo, G., Franzone, A., Trimarco, B., Esposito, G., & Perrino, C. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx342 · Cited by 563 · cited 1×
“Several clinical studies showed a direct association between TMAO levels and the risk for CV events and mortality in distinct populations, including patients with age-related diseases, such as heart failure, coronary artery disease or acute coronary syndrome, which was recently reinforced by systemic reviews and metaa…”
Heianza, Y., Ma, W., Manson, J. E., Rexrode, K. M., & Qi, L. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004947 · Cited by 544 · cited 1×
“Several clinical studies showed a direct association between TMAO levels and the risk for CV events and mortality in distinct populations, including patients with age-related diseases, such as heart failure, coronary artery disease or acute coronary syndrome, which was recently reinforced by systemic reviews and metaa…”
COVID-19: The Inflammation Link and the Role of Nutrition in Potential Mitigation
Zabetakis, I., Lordan, R., Norton, C., & Tsoupras, A. (2020) · Nutrients · doi:10.3390/nu12051466 · Cited by 532 · cited 1×
“Regarding nutraceutical interventions, several options able to modulate GM have been recently suggested as potentially useful in combating COVID-19 or its associated symptoms (Akour, 2020; Dhar and Mohanty, 2020; Zabetakis et al., 2020); among them, vitamins, selenium and zinc, flavonoids, omega‐3 polyunsaturated fatt…”
Santos, R. A. S., Ferreira, A. J., Verano-Braga, T., & Bader, M. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0341 · Cited by 523 · cited 1×
“promoting many opposite effects to those attributed to Ang II (Kuba et al., 2013; Santos et al., 2013).”
The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease
Anders, H.-J., Andersen, K., & Stecher, B. (2013) · Kidney International · doi:10.1038/ki.2012.440 · Cited by 493
(2020) · Asian Pacific Journal of Allergy and Immunology · doi:10.12932/ap-200220-0773 · Cited by 486 · cited 1×
“T inflammatory agents, as well as drugs targeting a functional receptor for SARS-CoV-2 entry into human cells, the angiotensin converting enzyme 2 (ACE2) (Li et al., 2020b; Sanders et al., 2020; Shanmugaraj et al., 2020; Zhang and Liu, 2020).”
Banerjee, A., Kulcsar, K., Misra, V., Frieman, M., & Mossman, K. (2019) · Viruses · doi:10.3390/v11010041 · Cited by 476
Role of Dietary Nutrients in the Modulation of Gut Microbiota: A Narrative Review
Yang, Q., Liang, Q., Balakrishnan, B., Belobrajdic, D. P., Feng, Q.-J., & Zhang, W. (2020) · Nutrients · doi:10.3390/nu12020381 · Cited by 466 · cited 1×
“, 2020); among them, vitamins, selenium and zinc, flavonoids, omega‐3 polyunsaturated fatty acids and a panoply of herbs/compounds from traditional chinese medicine (Costantini et al., 2017; Feng et al., 2019; Kumar Singh et al., 2019; Steinert et al., 2020; Yang et al., 2020).”
McIntyre, C. W., Harrison, L. E. A., Eldehni, M. T., Jefferies, H. J., Szeto, C.-C., John, S. G., Sigrist, M. K., Burton, J. O., Hothi, D., Korsheed, S., et al. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04610510 · Cited by 460 · cited 3×
“Mounting evidences coming from preclinical and clinical research strongly suggest that dysbiosis of intestinal microflora is involved in age-related cardiovascular, metabolic and renal diseases (McIntyre et al., 2011; Miele et al., 2015).”
Zhong, J., Basu, R., Guo, D., Chow, F. L., Byrns, S., Schuster, M., Loibner, H., Wang, X.-H., Penninger, J. M., Kassiri, Z., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.955369 · Cited by 457 · cited 3×
“Thus, the ACE2/Ang 1–7/MasR axis over time was established as the physiological counter-regulator of Ang II in the RAS (Patel et al., 2016; Zhong et al., 2010).”
[Management of COVID-19: the Zhejiang experience].
Xu, K., Cai, H., Shen, Y., Ni, Q., Chen, Y., Hu, S., Li, J., Wang, H., Yu, L., Huang, H., et al. (2020) · PubMed · doi:10.3785/j.issn.1008-9292.2020.02.02 · Cited by 452
Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden
Stubbs, J. R., House, J. A., Ocque, A. J., Zhang, S., Johnson, C., Kimber, C., Schmidt, K., Gupta, A., Wetmore, J. B., Nolin, T. D., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014111063 · Cited by 450 · cited 2×
“, 2017), as well as with atherosclerotic disease and long-term mortality in kidney disease patients (Stubbs et al., 2016; Tang et al., 2015).”
Roncon, L., Zuin, M., Rigatelli, G., & Zuliani, G. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104354 · Cited by 439 · cited 2×
“In fact, strong epidemiological and biochemical data coming from the COVID19 pandemics shows that elderly people with pre-existing cardiovascular, metabolic, renal, and lung diseases (including hypertension, coronary disease, diabetes, CKD and respiratory syndromes) are at higher risk of severe disease and mortality w…”
Kumar Singh, A., Cabral, C., Kumar, R., Ganguly, R., Kumar Rana, H., Gupta, A., Rosaria Lauro, M., Carbone, C., Reis, F., & Pandey, A. K. (2019) · Nutrients · doi:10.3390/nu11092216 · Cited by 433
Self-citationEpidemiology and clinical features of COVID-19: A review of current literature
Siordia, J. A. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104357 · Cited by 431 · cited 2×
“…pre-existing cardiovascular, metabolic and renal disorders, in whom the disease severity and the mortality rate are considerably higher (Du et al., 2020; Li et al., 2020a; Mehra et al., 2020; Roncon et al., 2020; Shi et al., 2020; Siordia, 2020; Team, 2020; Wang et al., 2020c; Zhou et al., 2020a).”
Meo, S. A., Alhowikan, A. M., Al-khlaiwi, T., Meo, I. M. U., Halepoto, D. M., Iqbal, M., Usmani, A. M., Hajjar, W. M., & Ahmed, N. (2020) · PubMed · doi:10.26355/eurrev_202002_20379 · Cited by 426 · cited 1×
“Severe cases often display respiratory, hepatic, gastrointestinal and neurological complications that ultimately culminate in hospitalization and death, with some differences in lethality when compared with the previous SARS‐CoV/ MERS‐CoV infections (Meo et al., 2020; Siordia, 2020).”
Shi, Q., Zhang, X., Jiang, F., Zhang, X., Hu, N., Bimu, C., Feng, J., Yan, S., Guan, Y., Xu, D., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0598 · Cited by 417 · cited 2×
“The percentage of persons hospitalized, who further need intensive care, increases with age, which is in line with the increased mortality rate in the elderly (Du et al., 2020; Shi et al., 2020; Team, 2020; Zhou et al., 2020a).”
Marshall, R. P., Webb, S., Bellingan, G. J., Montgomery, H. E., Chaudhari, B., McAnulty, R. J., Humphries, S. E., Hill, M. R., & Laurent, G. J. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2108086 · Cited by 412 · cited 1×
“In addition, RAS activation has been associated with acute lung injury and acute respiratory distress syndrome (Marshall et al., 2002).”
Mehta, N., Kalra, A., Nowacki, A. S., Anjewierden, S., Han, Z., Bhat, P., Carmona-Rubio, A. E., Jacob, M., Procop, G. W., Harrington, S., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1855 · Cited by 400 · cited 1×
“A study conducted with 18,472 patients tested for COVID-19 showed no association between ACEIs or ARBs use and COVID-19 test positivity (Mehta et al., 2020).”
SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?
Kuster, G. M., Pfister, O., Burkard, T., Zhou, Q., Twerenbold, R., Haaf, P., Widmer, A. F., & Osswald, S. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa235 · Cited by 395 · cited 1×
“Notably, an exacerbated inflammatory phenotype could be strengthened by an impaired RAS signaling due to the loss of ACE2-protective functions upon SARS-CoV-2 infection, further contributing to the systemic “cytokine storm” and tissue injury (Kuster et al., 2020; Wan et al., 2020; Wang et al., 2020b) (see Fig.”
Wang, X., Fang, X., Cai, Z., Wu, X., Gao, X., Min, J., & Wang, F. (2020) · Research · doi:10.34133/2020/2402961 · Cited by 387 · cited 1×
“Regarding the kidney, ACE2 is expressed in the brush border of the proximal tubule epithelial cells, where it contributes to regulate blood pressure and salt and fluid homeostasis (Warner et al., 2005).”
Gut microbiota, a new frontier to understand traditional Chinese medicines
Feng, W., Ao, H., Peng, C., & Yan, D. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.02.024 · Cited by 377 · cited 1×
“, 2020); among them, vitamins, selenium and zinc, flavonoids, omega‐3 polyunsaturated fatty acids and a panoply of herbs/compounds from traditional chinese medicine (Costantini et al., 2017; Feng et al., 2019; Kumar Singh et al., 2019; Steinert et al., 2020; Yang et al., 2020).”
ADAM-17: the enzyme that does it all
Gooz, M. (2010) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409231003628015 · Cited by 377 · cited 1×
“Notably, TACE overstimulation may culminate in RAS overactivation and both events have been reported in some cardiovascular inflammatory diseases, namely in heart failure and coronary artery disease (Gooz, 2010; Shen et al., 2018).”
Ageing of the human metaorganism: the microbial counterpart
Biagi, E., Candela, M., Fairweather-Tait, S., Franceschi, C., & Brigidi, P. (2012) · AGE · doi:10.1007/s11357-011-9217-5 · Cited by 365 · cited 1×
“Notably, this mutually maintained state between immunosenescence and inflammaging that ensues in the elderly is strongly modulated by changes in GM (Amsterdam and Ostrov, 2018; Biagi et al., 2012, 2013; Shaw et al., 2013).”
BackgroundHaschke, M., Schuster, M., Poglitsch, M., Loibner, H., Salzberg, M., Bruggisser, M., Penninger, J., & Krähenbühl, S. (2013) · Clinical Pharmacokinetics · doi:10.1007/s40262-013-0072-7 · Cited by 361 · cited 1×
“It is worth to mention that previous studies with the rhACE2 APN01 (GSK2586881) have shown a safe profile both in healthy volunteers as well as in a small cohort of patients with acute respiratory distress syndrome (Haschke et al., 2013; Khan et al., 2017; Zhang and Baker, 2017).”
Metabolic endotoxemia and diabetes mellitus: A systematic review
Gomes, J. M. G., Costa, J. D. A., & Alfenas, R. D. C. G. (2017) · Metabolism · doi:10.1016/j.metabol.2016.12.009 · Cited by 334 · cited 1×
“Notably, TACE overstimulation may culminate in RAS overactivation and both events have been reported in some cardiovascular inflammatory diseases, namely in heart failure and coronary artery disease (Gooz, 2010; Shen et al., 2018).”
Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome
Cheng, P. K., Wong, D. A., Tong, L. K., Ip, S.-M., Lo, A. C., Lau, C.-S., Yeung, E. Y., & Lim, W. W. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16255-7 · Cited by 332 · cited 1×
“previous CoVs outbreaks, the presence of viral RNA in feces was detected in a high percentage of patients with a more aggressive clinical course (Cheng et al., 2004).”
Patel, V. B., Clarke, N., Wang, Z., Fan, D., Parajuli, N., Basu, R., Putko, B., Kassiri, Z., Turner, A. J., & Oudit, G. Y. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.11.017 · Cited by 321 · cited 1×
“ACE2 is a counter-regulator of ACE activity mainly by converting angiotensin I (Ang I) into a nonapeptide (Ang 1–9) and angiotensin II (Ang II) into a vasoprotective heptapeptide (Ang 1–7) (Patel et al., 2014).”
Induction and function of type I and III interferon in response to viral infection
Levy, D. E., Marié, I. J., & Durbin, J. E. (2011) · Current Opinion in Virology · doi:10.1016/j.coviro.2011.11.001 · Cited by 314 · cited 1×
“Downstream signaling cascades foster viral antigens phagocytosis by host macrophages and play a major role in orchestrating the development of the adaptive immune response to infection (Levy et al., 2011; Yi et al., 2020).”
Pulmonary Angiotensin-Converting Enzyme 2 (ACE2) and Inflammatory Lung Disease
Jia, H. (2016) · Shock · doi:10.1097/shk.0000000000000633 · Cited by 294 · cited 2×
“Regarding acute lung injury of distinct etiologies, including the one induced by SARS-CoV, rhACE2 also promoted beneficial effects (Imai et al., 2005; Jia, 2016; Kuba et al., 2005).”
Camargo, S. M. R., Singer, D., Makrides, V., Huggel, K., Pos, K. M., Wagner, C. A., Kuba, K., Danilczyk, U., Skovby, F., Kleta, R., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.055 · Cited by 282 · cited 1×
“Further studies confirmed that ACE2 functions as the chaperone for membrane trafficking of the aminoacid transporter B°AT1, which mediates the uptake of neutral amino acids into intestinal cells in a sodium-dependent manner, even in the absence of collectrin (Camargo et al., 2009; Kowalczuk et al., 2008).”
Ageing and gut microbes: Perspectives for health maintenance and longevity
Biagi, E., Candela, M., Turroni, S., Garagnani, P., Franceschi, C., & Brigidi, P. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2012.10.005 · Cited by 276
Loss of Angiotensin-Converting Enzyme-2 (Ace2) Accelerates Diabetic Kidney Injury
Wong, D. W., Oudit, G. Y., Reich, H., Kassiri, Z., Zhou, J., Liu, Q. C., Backx, P. H., Penninger, J. M., Herzenberg, A. M., & Scholey, J. W. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060977 · Cited by 273
The Role of Immunosenescence in the Development of Age-Related Diseases
Fülöp, T., Dupuis, G., Witkowski, J. M., & Larbi, A. (2016) · Revista de Investigación Clínica · doi:10.1016/s0034-8376(25)00212-8 · Cited by 269
Angiotensin II and the fibroproliferative response to acute lung injury
Marshall, R. P., Gohlke, P., Chambers, R. C., Howell, D. C., Bottoms, S. E., Unger, T., McAnulty, R. J., & Laurent, G. J. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00313.2002 · Cited by 268 · cited 1×
“, 2008), in opposition to the effects reported for increased Ang II levels (Marshall et al., 2004).”
Angiotensin Converting Enzyme 2: A Double-Edged Sword
Wang, K., Gheblawi, M., & Oudit, G. Y. (2020) · Circulation · doi:10.1161/circulationaha.120.047049 · Cited by 265
Ferreira, A. J., Shenoy, V., Yamazato, Y., Sriramula, S., Francis, J., Yuan, L., Castellano, R. K., Ostrov, D. A., Oh, S. P., Katovich, M. J., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200811-1678oc · Cited by 245 · cited 1×
“In the lung, ACE2 seems to ameliorate pulmonary hypertension and pulmonary fibrosis (Ferreira et al., 2009; Li et al., 2008), in opposition to the effects reported for increased Ang II levels (Marshall et al.”
Contributions of the intestinal microbiome in lung immunity
McAleer, J. P., & Kolls, J. K. (2018) · European Journal of Immunology · doi:10.1002/eji.201646721 · Cited by 243 · cited 1×
“Accordingly, mounting evidences outline a key role for gut dysbiosis in age-related cardiovascular, metabolic and renal disorders (Abenavoli et al., 2019; Mafra et al., 2019; McAleer and Kolls, 2018; Sanchez-Rodriguez et al., 2020).”
ACE2 – From the renin–angiotensin system to gut microbiota and malnutrition
Perlot, T., & Penninger, J. M. (2013) · Microbes and Infection · doi:10.1016/j.micinf.2013.08.003 · Cited by 242 · cited 9×
“Mounting evidences suggested beneficial effects of ACE2 on several cardiovascular conditions involving the use of AMPs (such as LL-37, defensins or PR-39) and/or impact on gut microbiota (Ikeda et al., 2001; Kougias et al., 2005; Zhao et al., 2012).”
InfluentialWang, J., Li, F., Sun, R., Gao, X., Wei, H., Li, L.-J., & Tian, Z. (2013) · Nature Communications · doi:10.1038/ncomms3106 · Cited by 239
Zhang, H., Wada, J., Hida, K., Tsuchiyama, Y., Hiragushi, K., Shikata, K., Wang, H., Lin, S., Kanwar, Y. S., & Makino, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006723200 · Cited by 239 · cited 1×
“ACE2 shares great homology (around 50 %) with collectrin, a type 1 transmembrane protein that regulates the transporter of neutral amino acids in the kidney (Zhang et al., 2001).”
Impact of gut microbiota on diabetes mellitus
Blandino, G., Inturri, R., Lazzara, F., Di Rosa, M., & Malaguarnera, L. (2016) · Diabetes & Metabolism · doi:10.1016/j.diabet.2016.04.004 · Cited by 231 · cited 2×
“These MAMPs, through TLRs signaling, namely TLR4, cause a pro-inflammatory and immune response, thereby affecting glucose and insulin metabolism and/or signaling (Blandino et al., 2016).”
A protein complex in the brush‐border membrane explains a Hartnup disorder allele
Kowalczuk, S., Bröer, A., Tietze, N., Vanslambrouck, J. M., Rasko, J. E. J., & Bröer, S. (2008) · The FASEB Journal · doi:10.1096/fj.08-107300 · Cited by 220 · cited 1×
“Further studies confirmed that ACE2 functions as the chaperone for membrane trafficking of the aminoacid transporter B°AT1, which mediates the uptake of neutral amino acids into intestinal cells in a sodium-dependent manner, even in the absence of collectrin (Camargo et al., 2009; Kowalczuk et al., 2008).”
Sanchez-Rodriguez, E., Egea-Zorrilla, A., Plaza-Díaz, J., Aragón-Vela, J., Muñoz-Quezada, S., Tercedor-Sánchez, L., & Abadia-Molina, F. (2020) · Nutrients · doi:10.3390/nu12030605 · Cited by 214
Altered Gut Microbiome Profile in Patients With Pulmonary Arterial Hypertension
Kim, S., Rigatto, K., Gazzana, M. B., Knorst, M. M., Richards, E. M., Pepine, C. J., & Raizada, M. K. (2020) · Hypertension · doi:10.1161/hypertensionaha.119.14294 · Cited by 213 · cited 1×
“Coherently, a gut-lung axis has been proposed in the onset of pulmonary hypertension associated with a phenotype of gut dysbiosis and leaky gut linked with overactivation of the ACE/Ang II/AT1R axis due to ACE2 loss (Kim et al., 2020).”
Gut Microbiota, Host Organism, and Diet Trialogue in Diabetes and Obesity
Lazar, V., Ditu, L.-M., Pircalabioru, G. G., Picu, A., Petcu, L., Cucu, N., & Chifiriuc, M. C. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00021 · Cited by 210 · cited 1×
“Several studies showed a reduced diversity, resilience and impaired prevalence of Firmicutes to Bacterioidetes ratio (a marker of dysbiosis) in patients with obesity or type 2 diabetes mellitus (Burcelin, 2016; Lazar et al., 2019).”
Ye, R., & Liu, Z. (2020) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2019.104350 · Cited by 205 · cited 1×
“In further support of this thesis, LPS-induced acute lung injury in mice was able to reduce the expression of ACE2, exacerbating inflammatory injury and causing upregulation of other components of the RAS, namely renin, Ang II, ACE, and AT1 receptors (Ye and Liu, 2020).”
Using Corticosteroids to Reshape the Gut Microbiome: Implications for Inflammatory Bowel Diseases
Huang, E. Y., Inoue, T., Leone, V. A., Dalal, S., Touw, K., Wang, Y., Musch, M. W., Theriault, B., Higuchi, K., Donovan, S., et al. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000332 · Cited by 204 · cited 1×
“Concerning drugs, the anti-malarial drugs chloroquine and hydroxychloroquine, the lipidlowering drugs statins, together with immunomodulatory and anti-inflammatory agents such as some interferons and corticosteroids (including dexamethasone), have been shown to interfere with GM (Angelakis et al., 2014; Huang et al.,…”
Coronaviruses: Important Emerging Human Pathogens
Coleman, C. M., & Frieman, M. B. (2014) · Journal of Virology · doi:10.1128/jvi.03488-13 · Cited by 204 · cited 1×
“The lethality of coronaviruses infection after crossing this species barrier is high, as demonstrated by the outbreak of severe acute respiratory syndrome (SARS) in 2002, followed by the Middle East respiratory syndrome (MERS) in 2012, originated by SARS‐CoV and MERS‐CoV, respectively (Coleman and Frieman, 2014; Zumla…”
Angiotensin-Converting Enzyme 2 (ACE2) in Disease Pathogenesis
Imai, Y., Kuba, K., Ohto-Nakanishi, T., & Penninger, J. M. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0045 · Cited by 198 · cited 1×
“The role of this axis is of special relevance in conditions associated with RAS overactivation, which includes age-related cardiac, vascular, renal and respiratory diseases, among others (Cole-Jeffrey et al., 2015; Imai et al., 2010; Kuba et al., 2013).”
Multiple Functions of Angiotensin-Converting Enzyme 2 and Its Relevance in Cardiovascular Diseases
Kuba, K., Imai, Y., & Penninger, J. M. (2013) · Circulation Journal · doi:10.1253/circj.cj-12-1544 · Cited by 197 · cited 9×
“Apart from signaling through the MasR, Ang 1−7 can also act as an AT1R antagonist, further counteracting the ACE/Ang II/AT1R axis (Gironacci et al., 1999).”
InfluentialGut microbiota and immune crosstalk in metabolic disease
Burcelin, R. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.05.016 · Cited by 191 · cited 1×
“Several studies showed a reduced diversity, resilience and impaired prevalence of Firmicutes to Bacterioidetes ratio (a marker of dysbiosis) in patients with obesity or type 2 diabetes mellitus (Burcelin, 2016; Lazar et al., 2019).”
Protective Microbiota: From Localized to Long-Reaching Co-Immunity
Chiu, L., Bazin, T., Truchetet, M.-E., Schaeverbeke, T., Delhaes, L., & Pradeu, T. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01678 · Cited by 190 · cited 1×
“It is now well established that commensal microbiota (GI tract, oral, respiratory, genitourinary, and dermal) plays a central role in assembling mammalian immune effectors for an optimal antiviral immune response (Chiu et al., 2017).”
Response of host inflammasomes to viral infection
Chen, I.-Y., & Ichinohe, T. (2015) · Trends in Microbiology · doi:10.1016/j.tim.2014.09.007 · Cited by 189 · cited 2×
“For instance, secondary lymphoid tissues development at distal non-GI tract sites and differentiation/maturation of T and B cells (including virus-specific effectors CD4+ and CD8+ T cells) are extensively shaped by commensal gut microbiota (Chen and Ichinohe, 2015).”
Warner, F. J., Lew, R. A., Smith, A. I., Lambert, D. W., Hooper, N. M., & Turner, A. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508914200 · Cited by 183
Recombinant human ACE2: acing out angiotensin II in ARDS therapy
Zhang, H., & Baker, A. (2017) · Critical Care · doi:10.1186/s13054-017-1882-z · Cited by 183 · cited 1×
“It is worth to mention that previous studies with the rhACE2 APN01 (GSK2586881) have shown a safe profile both in healthy volunteers as well as in a small cohort of patients with acute respiratory distress syndrome (Haschke et al., 2013; Khan et al., 2017; Zhang and Baker, 2017).”
Li, X., Molina-Molina, M., Abdul-Hafez, A., Uhal, V., Xaubet, A., & Uhal, B. D. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00009.2008 · Cited by 182 · cited 1×
“In the lung, ACE2 seems to ameliorate pulmonary hypertension and pulmonary fibrosis (Ferreira et al., 2009; Li et al., 2008), in opposition to the effects reported for increased Ang II levels (Marshall et al.”
Garg, M., Angus, P., Burrell, L. M., Herath, C. B., Gibson, P. R., & Lubel, J. S. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04971.x · Cited by 180 · cited 2×
“In fact, local RAS is involved in the regulation of glucose, amino acid, fluid and electrolyte absorption and secretion, blood flow, motility and inflammation, and could be a promising target for GI disorders, such as inflammatory bowel disease, among others (Garg et al., 2012).”
Zhang, X., Yu, J., Pan, L.-Y., & Jiang, H.-Y. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104927 · Cited by 177
Gut-Microbiota-Metabolite Axis in Early Renal Function Decline
Barrios, C., Beaumont, M., Pallister, T., Villar, J., Goodrich, J. K., Clark, A., Pascual, J., Ley, R. E., Spector, T. D., Bell, J. T., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0134311 · Cited by 175
Gut microbiota metabolism of l-carnitine and cardiovascular risk
Ussher, J. R., Lopaschuk, G. D., & Arduini, A. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.10.013 · Cited by 170
Fernandes, R., Viana, S. D., Nunes, S., & Reis, F. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.09.032 · Cited by 168 · cited 4×
“Concurrently, signals coming from the dysbiotic gut microbiota modulate immunometabolism by interfering with epithelial and immune cells, generating an immune-inflammatory milieu that favors the progression of diabetes and its complication including diabetic retinopathy and nephropathy (Fernandes et al., 2019).”
InfluentialSelf-citationImpact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk
Miele, L., Giorgio, V., Alberelli, M. A., De Candia, E., Gasbarrini, A., & Grieco, A. (2015) · Current Cardiology Reports · doi:10.1007/s11886-015-0671-z · Cited by 163 · cited 1×
“Mounting evidences coming from preclinical and clinical research strongly suggest that dysbiosis of intestinal microflora is involved in age-related cardiovascular, metabolic and renal diseases (McIntyre et al., 2011; Miele et al., 2015).”
Guang, C., Phillips, R. D., Jiang, B., & Milani, F. (2012) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2012.02.010 · Cited by 161 · cited 1×
“Full-length ACE2 consists of an N- terminal peptidase domain (PD) and a C-terminal collectrin-like domain (CLD) that ends with a single transmembrane helix and an intracellular tail (Guang et al., 2012; Yan et al., 2020).”
p-cresylsulfate and indoxyl sulfate level at different stages of chronic kidney disease
Lin, C.-J., Chen, H.-H., Pan, C.-F., Chuang, C.-K., Wang, T.-J., Sun, F.-J., & Wu, C.-J. (2011) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.20456 · Cited by 159
Dietary Components That May Influence the Disturbed Gut Microbiota in Chronic Kidney Disease
Mafra, D., Borges, N., Alvarenga, L., Esgalhado, M., Cardozo, L., Lindholm, B., & Stenvinkel, P. (2019) · Nutrients · doi:10.3390/nu11030496 · Cited by 152 · cited 1×
“Accordingly, mounting evidences outline a key role for gut dysbiosis in age-related cardiovascular, metabolic and renal disorders (Abenavoli et al., 2019; Mafra et al., 2019; McAleer and Kolls, 2018; Sanchez-Rodriguez et al., 2020).”
Kanmani, P., Clua, P., Vizoso-Pinto, M. G., Rodriguez, C., Alvarez, S., Melnikov, V., Takahashi, H., Kitazawa, H., & Villena, J. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01613 · Cited by 140 · cited 1×
“Similarly, the impact of intestinal (and lung) commensal microorganisms on the fine tuning of host immunity upon distinct respiratory viruses infection is also wellknown (Grayson et al., 2018; Kanmani et al., 2017; Wang et al., 2013).”
Sun, G., Yin, Z., Liu, N., Bian, X., Yu, R., Su, X., Zhang, B., & Wang, Y. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.09.108 · Cited by 140 · cited 1×
“In fact, increased TMAO levels were associated with augmented tubulointerstitial fibrosis, promotion of renal oxidative stress and inflammation in animal models (Sun et al., 2017), as well as with atherosclerotic disease and long-term mortality in kidney disease patients (Stubbs et al.”
Ianiro, G., Mullish, B. H., Kelly, C. R., Sokol, H., Kassam, Z., Ng, S. C., Fischer, M., Allegretti, J. R., Masucci, L., Zhang, F., et al. (2020) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(20)30082-0 · Cited by 136 · cited 1×
“In this sense, an international group of experts in fecal microbiota transplantation and stool banking have suggested a rapid revision of recommendations in order to avoid contamination from donors, who should be carefully screened before donating (Ianiro et al., 2020).”
Innate Sensing of DNA Virus Genomes
Ma, Z., Ni, G., & Damania, B. (2018) · Annual Review of Virology · doi:10.1146/annurev-virology-092917-043244 · Cited by 136
BATLLE, D. C., Wysocki, J. A., Soler, M. J., & Ranganath, K. (2011) · Kidney International · doi:10.1038/ki.2011.381 · Cited by 126 · cited 1×
“Although ACE2 has been mostly associated with renoprotective effects in some animal models of nephropathy, including in diabetic kidney injury, namely by the reduction of Ang II levels and its pro-hypertensive and vasoconstrictor actions (Batlle et al., 2012; Wong et al., 2007), the renal injury induced by ACE2 and An…”
Uremic Toxins Overload Accelerates Renal Damage in a Rat Model of Chronic Renal Failure
Satoh, M., Hayashi, H., WATANABE, M., Ueda, K., Yamato, H., Yoshioka, T., & Motojima, M. (2003) · Nephron Experimental Nephrology · doi:10.1159/000074327 · Cited by 121 · cited 1×
“In addition, several other metabolites formed upon degradation of food constituents by dysbiotic microbiota include uremic toxics, such as indoxyl sulfate (IS) and p-cresyl sulfate (PCS), end-products of amino acids (tryptophan, tyrosine and phenylalanine) fermentation, causing renal fibrosis and aggravation of kidney…”
Vitamins for the Gut Microbiome
Steinert, R. E., Lee, Y.-K., & Sybesma, W. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.11.005 · Cited by 114 · cited 1×
“, 2020); among them, vitamins, selenium and zinc, flavonoids, omega‐3 polyunsaturated fatty acids and a panoply of herbs/compounds from traditional chinese medicine (Costantini et al., 2017; Feng et al., 2019; Kumar Singh et al., 2019; Steinert et al., 2020; Yang et al., 2020).”
He, Y., Wang, J., Li, F., & Shi, Y. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01302 · Cited by 114 · cited 1×
“Altogether, these emerging observations pave the way for incoming studies centered on gut microbiota and mammalian host immune relationships upon SARS-CoV-2 infection which may bring new faithfull insights for COVID-19 management (He et al., 2020).”
Morales, D. R., Conover, M. M., You, S. C., Pratt, N. L., Kostka, K., Duarte‐Salles, T., Fernández‐Bertolín, S., Aragón, M., DuVall, S. L., Lynch, K. E., et al. (2021) · PubMed · doi:10.1016/s2589-7500(20)30289-2 · Cited by 114
Angiotensin-(1–7) in kidney disease: a review of the controversies
Zimmerman, D., & Burns, K. D. (2012) · Clinical Science · doi:10.1042/cs20120111 · Cited by 111 · cited 1×
“, 2007), the renal injury induced by ACE2 and Ang 1−7 was paradoxically reported under other experimental conditions, including in diabetic nephropathy, deserving further clarification (Zimmerman and Burns, 2012).”
ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease Therapy
Cole-Jeffrey, C. T., Liu, M., Katovich, M. J., Raizada, M. K., & Shenoy, V. (2015) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000307 · Cited by 103 · cited 1×
“The role of this axis is of special relevance in conditions associated with RAS overactivation, which includes age-related cardiac, vascular, renal and respiratory diseases, among others (Cole-Jeffrey et al., 2015; Imai et al., 2010; Kuba et al., 2013).”
Mangiola (2018) · PubMed · doi:10.26355/eurrev_201811_16280 · Cited by 102 · cited 1×
“Bifidobacteria) and a reduced number of species producing butyrate, a short chain fatty acid (SCFA) that plays important metabolic functions and has a major role in maintaining the integrity of intestinal epithelium (Mangiola et al., 2018).”
Expression of Human ACE2 in Lactobacillus and Beneficial Effects in Diabetic Retinopathy in Mice
Verma, A., Xu, K., Du, T., Zhu, P., Liang, Z., Liao, S., Zhang, J., Raizada, M. K., Grant, M. B., & Li, Q. (2019) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2019.06.007 · Cited by 99
Busnelli, M., Manzini, S., & Chiesa, G. (2019) · Nutrients · doi:10.3390/nu12010079 · Cited by 98 · cited 7×
“Gut microbiota dysbiosis has been also associated with a diversity of age-related cardiac and vascular disorders, including hypertension, heart failure, myocardial infarction, stroke and coronary artery disease, among others (Busnelli et al., 2019; Sanchez-Rodriguez et al., 2020).”
InfluentialCheema, M. U., & Pluznick, J. L. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13155 · Cited by 97 · cited 1×
“Interestingly, increased Ang II levels has been shown to directly impact gut microbial composition and metabolomics in a sex-specific manner (Cheema and Pluznick, 2019).”
Tschurtschenthaler, M., Wang, J., Fricke, C., Fritz, T. M. J., Niederreiter, L., Adolph, T. E., Sarcevic, E., Künzel, S., Offner, F. A., Kalinke, U., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-305863 · Cited by 96
Probiotics and COVID‐19: is there any link?
Akour, A. A. (2020) · Letters in Applied Microbiology · doi:10.1111/lam.13334 · Cited by 96
Duan, Y., Prasad, R., Feng, D., Beli, E., Calzi, S. L., Longhini, A. L. F., Lamendella, R., Floyd, J. L., Dupont, M., Noothi, S. K., et al. (2019) · Circulation Research · doi:10.1161/circresaha.119.315743 · Cited by 95 · cited 2×
“Experimentally, gain or loss of ACE2 function have been associated with amelioration and worsening of leaky gut conditions, respectively (Duan et al., 2019; Hashimoto et al., 2012).”
Not just angiotensinases: new roles for the angiotensin-converting enzymes
Lambert, D., Clarke, N. E., & Turner, A. J. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0152-x · Cited by 92 · cited 1×
“The RAS plays a relevant role in different body’ organs (such as the heart, kidney, and lung) and systems (namely circulatory and renal), through both local actions and systemic effects, including the regulation of blood pressure and electrolyte and liquid homeostasis (Lambert et al., 2010).”
COVID-19: Gastrointestinal symptoms and potential sources of SARS-CoV-2 transmission
Kotfis, K., & Skonieczna-Żydecka, K. (2020) · Anaesthesiology Intensive Therapy · doi:10.5114/ait.2020.93867 · Cited by 87 · cited 2×
“This is aligned with the gastrointestinal (GI) symptoms, such as nausea and diarrhea, that have been reported in COVID-19 patients, suggesting an impact on gastrointestinal-enteric system (Kotfis and Skonieczna-Zydecka, 2020).”
BackgroundResultRecent Research Advances in Renin-Angiotensin-Aldosterone System Receptors
Azushima, K., Morisawa, N., Tamura, K., & Nishiyama, A. (2020) · Current Hypertension Reports · doi:10.1007/s11906-020-1028-6 · Cited by 79
Role of ACE2 in diastolic and systolic heart failure
Wang, W., Bodiga, S., Das, S. K., Lo, J., Patel, V. B., & Oudit, G. Y. (2011) · Heart Failure Reviews · doi:10.1007/s10741-011-9259-x · Cited by 77
Grayson, M. H., Camarda, L. E., Hussain, S.-R. A., Zemple, S. J., Hayward, M., Lam, V., Hunter, D., Santoro, J. L., Rohlfing, M. M., Cheung, D. S., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01587 · Cited by 75 · cited 1×
“Similarly, the impact of intestinal (and lung) commensal microorganisms on the fine tuning of host immunity upon distinct respiratory viruses infection is also wellknown (Grayson et al., 2018; Kanmani et al., 2017; Wang et al., 2013).”
BackgroundHe, X., Han, B., Mura, M., Xia, S., Wang, S., Ma, T., Liu, M., & Liu, Z. (2007) · Shock · doi:10.1097/shk.0b013e3180310f3a · Cited by 72
Cell-Specific Functions of ADAM17 Regulate the Progression of Thoracic Aortic Aneurysm
Shen, M., Hu, M., Fedak, P. W. M., Oudit, G. Y., & Kassiri, Z. (2018) · Circulation Research · doi:10.1161/circresaha.118.313181 · Cited by 70 · cited 1×
“Notably, TACE overstimulation may culminate in RAS overactivation and both events have been reported in some cardiovascular inflammatory diseases, namely in heart failure and coronary artery disease (Gooz, 2010; Shen et al., 2018).”
Kougias, P., Chai, H., Lin, P. H., Yao, Q., Lumsden, A. B., & Chen, C. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00332.x · Cited by 65 · cited 1×
“Mounting evidences suggested beneficial effects of ACE2 on several cardiovascular conditions involving the use of AMPs (such as LL-37, defensins or PR-39) and/or impact on gut microbiota (Ikeda et al., 2001; Kougias et al., 2005; Zhao et al., 2012).”
Cannata, F., Chiarito, M., Reimers, B., Azzolini, E., Ferrante, G., My, I., Viggiani, G., Panico, C., Regazzoli, D., Ciccarelli, M., et al. (2020) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvaa056 · Cited by 61 · cited 1×
“The study further supported the current professional society’s guidelines that discourage the discontinuation of ACEIs or ARBs in COVID-19 patients due to lower risk of mortality when therapy is maintained (Cannata et al., 2020).”
Angiotensin-(1–7) binds at the type 1 angiotensin II receptors in rat renal cortex
Gironacci, M. M., Coba, M. P., & Peña, C. (1999) · Regulatory Peptides · doi:10.1016/s0167-0115(99)00067-1 · Cited by 60 · cited 1×
“Apart from signaling through the MasR, Ang 1−7 can also act as an AT1R antagonist, further counteracting the ACE/Ang II/AT1R axis (Gironacci et al., 1999).”
Kashtanova, D. A., Tkacheva, O. N., Strazhesko, I. D., Dudinskaya, Е. N., Kotovskaya, Y. V., Popenko, A., Tyakht, A., & Alexeev, D. G. (2019) · Healthy ageing and longevity · doi:10.1007/978-3-030-24970-0_17 · Cited by 59
A long-distance relationship: the commensal gut microbiota and systemic viruses
Winkler, E. S., & Thackray, L. B. (2019) · Current Opinion in Virology · doi:10.1016/j.coviro.2019.05.009 · Cited by 59
Huang, S., Shu, K.-H., Cheng, C.-H., Wu, M., Yu, T., Chuang, Y., & Chen, C. (2012) · Transplantation Proceedings · doi:10.1016/j.transproceed.2011.11.023 · Cited by 47 · cited 1×
“Serum levels of IS and PCS are negatively correlated with renal function and gradually increases with kidney disease severity (Huang et al., 2012; Lin et al., 2011).”
Ikeda, Y. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00226-1 · Cited by 44 · cited 1×
“Mounting evidences suggested beneficial effects of ACE2 on several cardiovascular conditions involving the use of AMPs (such as LL-37, defensins or PR-39) and/or impact on gut microbiota (Ikeda et al., 2001; Kougias et al., 2005; Zhao et al., 2012).”
The Impact of the Microbiome on Immunosenescence
Amsterdam, D., & Ostrov, B. E. (2018) · Immunological Investigations · doi:10.1080/08820139.2018.1537570 · Cited by 41
Zhao, H., Yan, H., Yamashita, S., Li, W., Liu, C., Chen, Y., Zhou, P., Chi, Y., Wang, S., Zhao, B., et al. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.10108 · Cited by 39 · cited 1×
“Mounting evidences suggested beneficial effects of ACE2 on several cardiovascular conditions involving the use of AMPs (such as LL-37, defensins or PR-39) and/or impact on gut microbiota (Ikeda et al., 2001; Kougias et al., 2005; Zhao et al., 2012).”
The Expression Changes of Inflammasomes in the Aging Rat Kidneys
Song, F., Ma, Y., Bai, X.-Y., & Chen, X. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glv078 · Cited by 34 · cited 1×
“Hence, the threshold for full inflammasome activation by a “second hit” (for instance, a viral infection) might be reached easier with ageing, analogous to what has been reported in vascular and renal patients (Song et al., 2016; Wu et al., 2015).”
Kawashima, T., Ikari, N., Watanabe, Y., Kubota, Y., Yoshio, S., Kanto, T., Motohashi, S., Shimojo, N., & Tsuji, N. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00027 · Cited by 34 · cited 1×
“Thus, an interconnected immune program with differential immunological reactions for pathogenic or commensal microorganisms-derived signals occurs through PRRs expressing cells, based on the ligand (PAMPs or MAMPs), cell type and/or receptors involved (Kawashima et al., 2018).”
BackgroundFuellen, G., Liesenfeld, O., Kowald, A., Barrantes, I., Bastian, M., Simm, A., Jansen, L., Tietz-Latza, A., Quandt, D., Franceschi, C., et al. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101091 · Cited by 31 · cited 1×
“Accordingly, new biomarkers directed towards a deep understanding of how age-related mechanisms modulate respiratory SARS-CoV-2 infectious disease may have longterm gain in COVID-19 pandemic, as recently highlighted (Fuellen et al., 2020).”
Wu, X., Hakimi, M., Wortmann, M., Zhang, J., Böckler, D., & Dihlmann, S. (2015) · Immunity & Ageing · doi:10.1186/s12979-015-0043-y · Cited by 31
Shifts in the gut microbiota of mice in response to dexamethasone administration
Zhao, H., Jiang, X., & Chu, W. (2020) · International Microbiology · doi:10.1007/s10123-020-00129-x · Cited by 30 · cited 1×
“Concerning drugs, the anti-malarial drugs chloroquine and hydroxychloroquine, the lipidlowering drugs statins, together with immunomodulatory and anti-inflammatory agents such as some interferons and corticosteroids (including dexamethasone), have been shown to interfere with GM (Angelakis et al., 2014; Huang et al.,…”
The human duodenal mucosa harbors all components for a local renin angiotensin system
Spak, E., Hallersund, P., Edebo, A., Casselbrant, A., & Fändriks, L. (2019) · Clinical Science · doi:10.1042/cs20180877 · Cited by 11
Cited by
Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications
Zhang, F., Lau, R. I., Liu, Q., Su, Q., Chan, F. K. L., & Ng, S. C. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00698-4 · Cited by 267
Biomarkers of post-covid depression
Lorkiewicz, P., & Waszkiewicz, N. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10184142 · Cited by 102
Algae-derived bioactive molecules for the potential treatment of SARS-CoV-2
Alam, M. A., Parra-Saldivar, R., Bilal, M., Afroze, C. A., Ahmed, M. N., Iqbal, H. M. N., & Xu, J. (2021) · Molecules · doi:10.3390/molecules26082134 · Cited by 69
“The putative association between ACE2 shedding after SARS-CoV-2 infection is shown in Figure 2 [56].”
BackgroundPost-COVID-19 Parkinsonism and Parkinson’s Disease Pathogenesis: The Exosomal Cargo Hypothesis
Mysiris, D. S., Vavougios, G. D., Karamichali, E., Papoutsopoulou, S., Stavrou, V. T., Papayianni, E., Boutlas, S., Mavridis, T., Foka, P., Zarogiannis, S. G., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179739 · Cited by 25
“On top of that, gut microbiota imbalance due to extrapulmonary SARS-CoV-2 infection has also been observed in COVID-19 [107,108].”
Background
Metadata
- Authors
- Viana, S. D., Nunes, S., & Reis, F.
- Venue
- Ageing Research Reviews
- Publisher
- Elsevier BV
- Published
- 2020-09
- Volume
- 62
- Pages
- 101123
- ISSN
- 1568-1637 (ISSN-L)
- OpenAlex
- W3042693379
- Cited by
- 185
- References
- 172
- FWCI
- 1.88
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.